These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 11550120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
    Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A, Cleeren M, Wostenborghs R, De Beule K.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397
    [Abstract] [Full Text] [Related]

  • 3. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
    Caillot D.
    Acta Haematol; 2003 Mar; 109(3):111-8. PubMed ID: 12714819
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of intravenous itraconazole followed by oral itraconazole solution in the treatment of invasive pulmonary mycosis.
    Zhang YY, Zhou X, National Collaborative Group of Sequential Itraconazole Treatment for Invasive Pulmonary Mycosis.
    Chin Med J (Engl); 2011 Oct; 124(20):3415-9. PubMed ID: 22088546
    [Abstract] [Full Text] [Related]

  • 8. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y.
    J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.
    Conway SP, Etherington C, Peckham DG, Brownlee KG, Whitehead A, Cunliffe H.
    J Antimicrob Chemother; 2004 May; 53(5):841-7. PubMed ID: 15044430
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. European experience with oral solution and intravenous itraconazole.
    Potter M.
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group].
    Tsubura E.
    Kekkaku; 1997 Oct; 72(10):557-64. PubMed ID: 9386354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.